Exploring the Potential of Sulfonamide-Dihydropyridine Hybrids as Multitargeted Ligands for Alzheimer's Disease Treatment

被引:3
作者
Dakhlaoui, Imen [1 ,2 ]
Bernard, Paul J. [1 ]
Pietrzak, Diana [3 ]
Simakov, Alexey [4 ]
Maj, Maciej [3 ]
Refouvelet, Bernard [1 ]
Beduneau, Arnaud [4 ]
Cornu, Raphael [4 ]
Jozwiak, Krzysztof [3 ]
Chabchoub, Fakher [2 ]
Iriepa, Isabel [5 ]
Martin, Helene [4 ]
Marco-Contelles, Jose [6 ]
Ismaili, Lhassane [1 ]
机构
[1] Univ Franche Comte, Lab LINC, Pole Chim Med, UR 481, F-25000 Besancon, France
[2] Univ Sfax, Fac Sci Sfax, Lab Appl Chem, Heterocycles Lipids & Polymers, BP 802, Sfax 3000, Tunisia
[3] Med Univ Lublin, Dept Biopharm, Ul W Chodzki 4a, PL-20093 Lublin, Poland
[4] Univ Franche Comte, PEP EA4267, F-25000 Besancon, France
[5] Univ Alcala, Dept Organ Chem & Inorgan Chem, Km 33 6, Alcala De Henares 28871, Barcelona, Spain
[6] CSIC, Lab Med Chem IQOG, C-Juan Cierva 3, Madrid 28006, Spain
关键词
calcium channel antagonism; cholinesterase inhibition; Hantzsch reaction; multitarget directed ligands; Nrf2; OXIDATIVE STRESS; THERAPEUTIC TARGET; MELATONIN; NRF2; ANTIOXIDANT; INHIBITORS; PATHWAY; BUTYRYLCHOLINESTERASE; INFLAMMATION; HYPOTHESIS;
D O I
10.3390/ijms24119742
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Alzheimer's disease (AD) is a multifactorial neurodegenerative disease that has a heavy social and economic impact on all societies and for which there is still no cure. Multitarget-directed ligands (MTDLs) seem to be a promising therapeutic strategy for finding an effective treatment for this disease. For this purpose, new MTDLs were designed and synthesized in three steps by simple and cost-efficient procedures targeting calcium channel blockade, cholinesterase inhibition, and antioxidant activity. The biological and physicochemical results collected in this study allowed us the identification two sulfonamide-dihydropyridine hybrids showing simultaneous cholinesterase inhibition, calcium channel blockade, antioxidant capacity and Nrf2-ARE activating effect, that deserve to be further investigated for AD therapy.
引用
收藏
页数:17
相关论文
共 50 条
  • [31] Development of Phthalimide-Donepezil Hybrids as Potent Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease
    Yu, Lintao
    Shi, Jian
    Cheng, Xinfeng
    Wang, Keren
    Liu, Shuang
    Liu, Wenmin
    Sang, Zhipei
    LETTERS IN DRUG DESIGN & DISCOVERY, 2020, 17 (09) : 1155 - 1163
  • [32] A review on the hybrids of hydroxycinnamic acid as multi-target-directed ligands against Alzheimer's disease
    Zhang, Xiao
    He, Xixin
    Chen, Qiuhe
    Lu, Junfeng
    Rapposelli, Simona
    Pi, Rongbiao
    BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (03) : 543 - 550
  • [33] Tacrine-hydroxamate derivatives as multitarget-directed ligands for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluation
    Xu, Ana
    He, Feng
    Zhang, Xiangna
    Li, Xiaoyang
    Ran, Yingying
    Wei, Chao
    Chou, C. James
    Zhang, Rui
    Wu, Jingde
    BIOORGANIC CHEMISTRY, 2020, 98
  • [34] Synthesis and evaluation of multi-target-directed ligands with BACE-1 inhibitory and Nrf2 agonist activities as potential agents against Alzheimer's disease
    Qu, Lailiang
    Ji, Limei
    Wang, Cheng
    Luo, Heng
    Li, Shang
    Peng, Wan
    Yin, Fucheng
    Lu, Dehua
    Liu, Xingchen
    Kong, Lingyi
    Wang, Xiaobing
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 219
  • [35] Multitarget Tacrine Hybrids with Neuroprotective Properties to Confront Alzheimer's Disease
    Spilovska, Katarina
    Korabecny, Jan
    Nepovimova, Eugenie
    Dolezal, Rafael
    Mezeiova, Eva
    Soukup, Ondrej
    Kuca, Kamil
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2017, 17 (09) : 1006 - 1026
  • [36] Benzenediol-berberine hybrids: Multifunctional agents for Alzheimer's disease
    Jiang, Huailei
    Wang, Xu
    Huang, Ling
    Luo, Zonghua
    Su, Tao
    Ding, Ke
    Li, Xingshu
    BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (23) : 7228 - 7235
  • [37] Synthesis and evaluation of 7,8-dehydrorutaecarpine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease
    He, Yan
    Yao, Pei-Fen
    Chen, Shuo-bin
    Huang, Zhi-hong
    Huang, Shi-Liang
    Tan, Jia-Heng
    Li, Ding
    Gu, Lian-Quan
    Huang, Zhi-Shu
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 63 : 299 - 312
  • [38] The potential roles of ATF family in the treatment of Alzheimer?s disease
    Yang, Ting
    Zhang, Yuhong
    Chen, Lixuan
    Thomas, Elizabeth Rosalind
    Yu, Wenjing
    Cheng, Bo
    Li, Xiang
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 161
  • [39] Xanthone: Potential Acetylcholinesterase Inhibitor for Alzheimer's Disease Treatment
    Vanessa, Vincentsia Vienna
    Mah, Siau Hui
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2021, 21 (17) : 2507 - 2529
  • [40] A potential role for crystallization inhibitors in treatment of Alzheimer's disease
    Grases, Felix
    Costa-Bauza, Antonia
    Prieto, Rafael M.
    MEDICAL HYPOTHESES, 2010, 74 (01) : 118 - 119